• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Dis . Clinical Outcomes and Immunologic Characteristics of Covid-19 in People With HIV

tetano

Editor, Senior Moderator
J Infect Dis


. 2020 Jun 30;jiaa380.
doi: 10.1093/infdis/jiaa380. Online ahead of print.
Clinical Outcomes and Immunologic Characteristics of Covid-19 in People With HIV

Hsi-En Ho[SUP] 1 [/SUP], Michael J Peluso[SUP] 2 [/SUP], Colton Margus[SUP] 1 [/SUP], Joao Pedro Matias Lopes[SUP] 1 [/SUP], Chen He[SUP] 1 [/SUP], Michael M Gaisa[SUP] 1 [/SUP], Georgina Osorio[SUP] 1 [/SUP], Judith A Aberg[SUP] 1 [/SUP], Michael P Mullen[SUP] 1 [/SUP]


AffiliationsExpand

Abstract

We performed a retrospective study of Covid-19 in people with HIV (PWH). PWH with Covid-19 demonstrated severe lymphopenia and decreased CD4+ T cell counts. Levels of inflammatory markers, including C-reactive protein, fibrinogen, D-dimer, interleukin-6, interleukin-8, and TNF-alpha were commonly elevated. In all, 19/72 hospitalized individuals (26.4%) died and 53 (73.6%) recovered. PWH who died had higher levels of inflammatory markers and more severe lymphopenia than those who recovered. These findings suggest that PWH remain at risk for severe manifestations of Covid-19 despite ART and that those with increased markers of inflammation and immune dysregulation are at risk for worse outcomes.

Keywords: Covid-19; HIV; SARS-CoV-2; coronavirus; inflammation; people living with HIV.
 
Back
Top Bottom